Drug for early menopause to improve fertility
Part of Hormones & metabolism clinical trials.
This study tests an experimental drug called YB-1113 for women with premature ovarian insufficiency (early menopause). The goal is to help your ovaries work better so you may become fertile. It is an early-stage trial focusing on safety and how well the drug works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 39 and want to preserve or improve your fertility
- You have had irregular or no periods for at least 4 months
- Your blood tests show high FSH (a hormone related to menopause) and low AMH (a marker of egg supply)
- You are generally healthy, without major medical conditions like cancer, heart problems, or certain hormonal disorders
- If you used birth control pills before, your periods have been absent for more than 3 months (or 6 months for certain injections)
- You are not pregnant, breastfeeding, or using an intrauterine device (IUD)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called finerenone to see if it can help women with premature ovarian insufficiency (early menopause). It may help restore ovarian function and improve quality of life.
This trial tests whether a hormone injection called HCG can activate dormant egg follicles in women under 40 who have gone through premature ovarian insufficiency (POI). If successful, it may help these women conceive.
This trial tests whether an immune-modulating drug can restart ovulation and improve fertility in women whose ovaries stopped working due to autoimmune disease. It is for women ages 18–38 with autoimmune premature ovarian insufficiency and certain antibodies.
This trial tests whether hormone replacement therapy (HRT) helps protect bone health in teenagers with premature ovarian insufficiency (POI). It compares HRT to a placebo and also includes healthy volunteers for comparison.
This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.
This trial tests whether injecting your own PRP (platelet-rich plasma) into the ovaries can improve ovarian function in some menopausal women. It may help those whose menopause seems less advanced, but not everyone will be eligible based on health and test results.
Hear when a new POI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.